Lynn Mullowney Supports I-181

I-181 will promote developing treatments and cures for brain diseases including but not limited to Alzheimer’s, Parkinson’s, brain cancer, dementia, traumatic brain injury, multiple sclerosis, autism, schizophrenia, depression, addiction disorders, diabetes, epilepsy, ALS, and post traumatic stress disorder. Join Lynn Mullowney, Executive Director at the Alzheimer’s Association Montana Chapter, in voting YES for I-181 on… Read More »